← All organizations

Northwest Biotherapeutics

For profitWebsite ↗

Also known as: Northwest Biotherapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2018

Timeline

1990s

Jun 1, 1998
Northwest Biotherapeutics— Founded

Drugs by trial phase (4 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

tumor-pulsed dendritic cells

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (10)

NCT03638765Lead sponsorPhase 1Nov 30, 2018
NCT03014804CollaboratorPhase 2Aug 1, 2017
NCT02146066Lead sponsorN/AMay 21, 2014
NCT01882946Study directorPhase 1/Phase 2Jun 1, 2013
NCT01882946Lead sponsorPhase 1/Phase 2Jun 1, 2013
NCT00603460CollaboratorPhase 1/Phase 2Jan 1, 2012
NCT00683241CollaboratorPhase 1Nov 1, 2007
NCT00045968Study directorPhase 3Dec 1, 2006
NCT00045968Lead sponsorPhase 3Dec 1, 2006
NCT00043212Lead sponsorPhase 3Aug 6, 2002

Details

Founded: Bethesda, MD, US Jun 1, 1998
Last known activity: Nov 30, 2018